Form 4: Arteris CEO Charles Janac Executes Stock Sale

Arteris, Inc. President and CEO Charles Janac sold 70,000 shares of common stock via a pre-arranged 10b5-1 trading plan.

Summary

• President and CEO Charles Janac sold a total of 70,000 shares of Arteris, Inc. common stock on June 8, 2026.
• The sales were executed in two tranches: 42,449 shares at a weighted average price of $34.7417 and 27,551 shares at a weighted average price of $35.1596.
• The transactions were conducted through Bayview Legacy, LLC, an entity over which the CEO holds voting and dispositive power.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed through a pre-planned 10b5-1 program, which is standard practice for executive financial planning.

Positives

• The sale was conducted under a pre-established 10b5-1 trading plan, which is a standard mechanism for executives to sell stock without triggering insider trading concerns.

Negatives

• The sale represents a reduction in the CEO's indirect beneficial ownership stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal of management's view on the company's near-term valuation.

Future Outlook

No forward-looking guidance or operational outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales via 10b5-1 plans are routine corporate governance events and generally do not reflect a change in company strategy or fundamental health.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for executives to manage personal liquidity while maintaining compliance with SEC regulations.

Stakeholder Impact

• Minimal impact expected as the sale was pre-planned and disclosed in accordance with regulatory requirements.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Arteris, AIP, Insider Trading, Form 4, Charles Janac, Stock Sale, 10b5-1